APTIMMUNE BIOLOGICS Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • APTIMMUNE BIOLOGICS's estimated annual revenue is currently $1.4M per year.(i)
  • APTIMMUNE BIOLOGICS's estimated revenue per employee is $155,000

Employee Data

  • APTIMMUNE BIOLOGICS has 9 Employees.(i)
  • APTIMMUNE BIOLOGICS grew their employee count by 0% last year.

APTIMMUNE BIOLOGICS's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79.1M5106%N/AN/A
#2
$1.1M717%N/AN/A
#3
$4.2M27-32%N/AN/A
#4
$2M1330%N/AN/A
#5
$4.3M284%N/AN/A
#6
$0.9M60%N/AN/A
#7
$5M323%N/AN/A
#8
$3.7M244%N/AN/A
#9
$0.3M40%N/AN/A
#10
$6M3950%N/AN/A
Add Company

What Is APTIMMUNE BIOLOGICS?

Aptimmune Biologics specializes in developing revolutionary mucosal vaccines that provide unsurpassed efficacy against the viral diseases most costly to the swine industry. We focus on swine vaccines and the prevention of two major diseases – Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9-10%N/A
#2
N/A90%N/A
#3
$0.7M90%N/A
#4
$0.7M90%N/A
#5
$0.7M9-76%N/A